Lineage Cell Therapeutics (formerly known as BioTime) is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. It develops a cell-based therapy platform that manufactures specialized, terminally-differentiated human cells from its pluripotent and progenitor cell starting materials.